Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D. [Yahoo! Finance]
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.
Turn Therapeutics' GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine [Yahoo! Finance]